Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Beijing, 100730, China.
Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
World J Surg Oncol. 2024 Sep 27;22(1):255. doi: 10.1186/s12957-024-03534-y.
To report a new case of gastroblastoma and conduct an exhaustive review of the clinical, morphological, immunohistochemical, molecular features, diagnosis, treatment, and prognosis, to enhance understanding of this condition.
We retrospectively analyzed the case of a 50-year-old woman diagnosed with gastroblastoma and conducted a review and summary of relevant literature.
To date, 27 cases have been reported, including the present case. The mean patient age at the time of presentation was 35.0 years (range, 5-74 years), and the disease showed no sex predilection. The most common location was the gastric antrum, and the average lesions size was 5.7 cm (range, 1.3-15 cm). Most patients underwent gastrectomy(n = 23), while several underwent ESD(n = 2) or EFTR(n = 1). Fusion genes were identified, including MALAT1-GLI1(n = 8), EWSR1-CTBP1(n = 1), PTCH1:GLI2(n = 1), and ACTB-GLI1(n = 1)Four patients had metastasis and one of them dead of disease. Immunohistochemical (IHC) analysis revealed that pancytokeratin was always positive in epithelioid components, while vimentin and CD10 were always positive in mesenchymal components. CD56 were often positive in both two components.
A comprehensive evaluation of clinical and pathological features is crucial for accurate diagnosis. Partial gastrectomy and EFTR could be an appropriate treatment. The risk factors that affect the prognosis need more cases to be clearly defined. We present this exhaustive literature review to increase awareness of gastroblastoma, better characterize the disease, and provide a reference point for gastroblastoma research in the future.
报告 1 例胃母细胞瘤病例,并对其临床、形态学、免疫组织化学、分子特征、诊断、治疗和预后进行全面回顾,以提高对该病的认识。
我们回顾性分析了 1 例 50 岁女性胃母细胞瘤患者的病例,并对相关文献进行了复习和总结。
迄今为止,共报道了 27 例病例,包括本病例。患者就诊时的平均年龄为 35.0 岁(范围,5-74 岁),无性别偏好。最常见的部位是胃窦,平均病变大小为 5.7cm(范围,1.3-15cm)。大多数患者接受了胃切除术(n=23),少数患者接受了内镜黏膜下剥离术(n=2)或内镜全层切除术(n=1)。鉴定出融合基因,包括 MALAT1-GLI1(n=8)、EWSR1-CTBP1(n=1)、PTCH1:GLI2(n=1)和 ACTB-GLI1(n=1)。4 例患者发生转移,其中 1 例死于疾病。免疫组织化学(IHC)分析显示上皮样成分中细胞角蛋白总是阳性,间叶成分中波形蛋白和 CD10 总是阳性,两种成分中 CD56 通常阳性。
全面评估临床和病理特征对于准确诊断至关重要。部分胃切除术和 EFTR 可能是一种合适的治疗方法。影响预后的危险因素需要更多的病例来明确。我们呈现这篇详尽的文献综述,旨在提高对胃母细胞瘤的认识,更好地描述该疾病,并为未来的胃母细胞瘤研究提供参考点。